{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:30:37Z","timestamp":1794864637813,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41409-025-02728-6","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T15:34:07Z","timestamp":1759764847000},"page":"26-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Upfront memory T cell add-back with haploidentical TCR\u03b1\u03b2-depleted graft in adults with haematological malignancies: a nationwide, multicentre, single-arm, prospective study"],"prefix":"10.1038","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8298-647X","authenticated-orcid":false,"given":"Liang-Piu","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8098-2590","authenticated-orcid":false,"given":"Yeh Ching","family":"Linn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Liang","family":"Boo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi Yi","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Quek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein","family":"Than","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin Phipps","family":"Diong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balamurugan","family":"Vellayappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1299-8560","authenticated-orcid":false,"given":"Aloysius","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0143-6263","authenticated-orcid":false,"given":"William","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lip Kun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Rachel M.","family":"Catapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kheng Wei","family":"Yeoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Shen","family":"Looi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tertius Tansloan","family":"Tuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teck Guan","family":"Soh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee Khiang","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin Jie","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"2728_CR1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1182\/bloodadvances.2016002386","volume":"1","author":"J Versluis","year":"2017","unstructured":"Versluis J, Labopin M, Ruggeri A, Socie G, Wu D, Volin L, et al. Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1. Blood Adv. 2017;1:477\u201385.","journal-title":"Blood Adv"},{"key":"2728_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.796349","volume":"13","author":"AD Hadjis","year":"2022","unstructured":"Hadjis AD, Nunes NS, Khan SM, Fletcher RE, Pohl AdeP, Venzon DJ, et al. Post-transplantation cyclophosphamide uniquely restrains alloreactive CD4+ T-Cell proliferation and differentiation after murine MHC-haploidentical hematopoietic cell transplantation. Front Immunol. 2022;13:796349.","journal-title":"Front Immunol"},{"key":"2728_CR3","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1080\/1744666X.2022.2134857","volume":"18","author":"R Handgretinger","year":"2022","unstructured":"Handgretinger R, Arendt A-M, Maier C-P, Lang P. Ex vivo and in vivo T-cell depletion in allogeneic transplantation: towards less or non-cytotoxic conditioning regimens. Expert Rev Clin Immunol. 2022;18:1285\u201396.","journal-title":"Expert Rev Clin Immunol"},{"key":"2728_CR4","first-page":"3996","volume":"95","author":"RE Champlin","year":"2000","unstructured":"Champlin RE, Passweg JR, Zhang MJ, Rowlings PA, Pelz CJ, Atkinson KA, et al. T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood. 2000;95:3996\u20134003.","journal-title":"Blood"},{"key":"2728_CR5","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1182\/blood.V78.8.2139.2139","volume":"78","author":"JH Antin","year":"1991","unstructured":"Antin JH, Bierer BE, Smith BR, Ferrara J, Guinan EC, Sieff C, et al. Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies. Blood. 1991;78:2139\u201349.","journal-title":"Blood"},{"key":"2728_CR6","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1200\/JCO.1992.10.7.1191","volume":"10","author":"RJ Soiffer","year":"1992","unstructured":"Soiffer RJ, Murray C, Mauch P, Anderson KC, Freedman AS, Rabinowe SN, et al. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. J Clin Oncol. 1992;10:1191\u2013200.","journal-title":"J Clin Oncol"},{"key":"2728_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/00007890-199401000-00015","volume":"57","author":"SD Nimer","year":"1994","unstructured":"Nimer SD, Giorgi J, Gajewski JL, Ku N, Schiller GJ, Lee K, et al. Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial. Transplantation. 1994;57:82\u20137.","journal-title":"Transplantation"},{"key":"2728_CR8","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1182\/blood.2022015959","volume":"140","author":"MA Pulsipher","year":"2022","unstructured":"Pulsipher MA, Ahn KW, Bunin NJ, Lalefar N, Anderson E, Flower A, et al. KIR-favorable TCR-\u03b1\u03b2\/CD19-depleted haploidentical HCT in children with ALL\/AML\/MDS: primary analysis of the PTCTC ONC1401 trial. Blood. 2022;140:2556\u201372.","journal-title":"Blood"},{"key":"2728_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41409-021-01551-z","volume":"57","author":"WA Bethge","year":"2022","unstructured":"Bethge WA, Eyrich M, Mielke S, Meisel R, Niederwieser D, Schlegel PG, et al. Results of a multicenter phase I\/II trial of TCR\u03b1\u03b2 and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients. Bone Marrow Transpl. 2022;57:423\u201330.","journal-title":"Bone Marrow Transpl"},{"key":"2728_CR10","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1182\/blood-2007-08-109678","volume":"111","author":"H Zheng","year":"2008","unstructured":"Zheng H, Matte-Martone C, Li H, Anderson BE, Venketesan S, Sheng Tan H, et al. Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease. Blood. 2008;111:2476\u201384.","journal-title":"Blood"},{"key":"2728_CR11","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1182\/blood-2003-08-2987","volume":"103","author":"BJ Chen","year":"2004","unstructured":"Chen BJ, Cui X, Sempowski GD, Liu C, Chao NJ. Transfer of allogeneic CD62L\u2013 memory T cells without graft-versus-host disease. Blood. 2004;103:1534\u201341.","journal-title":"Blood"},{"key":"2728_CR12","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1182\/blood-2006-04-016410","volume":"109","author":"BJ Chen","year":"2007","unstructured":"Chen BJ, Deoliveira D, Cui X, Le NT, Son J, Whitesides JF, et al. Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse. Blood. 2007;109:3115\u201323.","journal-title":"Blood"},{"key":"2728_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.hemonc.2017.05.006","volume":"10","author":"W Huang","year":"2017","unstructured":"Huang W, Chao NJ. Memory T cells: a helpful guard for allogeneic hematopoietic stem cell transplantation without causing graft-versus-host disease. Hematol Oncol Stem Cell Ther. 2017;10:211\u20139.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"2728_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13045-024-01567-0","volume":"17","author":"S Naik","year":"2024","unstructured":"Naik S, Li Y, Talleur AC, Selukar S, Ashcraft E, Cheng C, et al. Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial. J Hematol Oncol. 2024;17:50.","journal-title":"J Hematol Oncol"},{"key":"2728_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41\u201355.","journal-title":"Biometrika"},{"key":"2728_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46:399\u2013424.","journal-title":"Multivariate Behav Res"},{"key":"2728_CR17","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1182\/blood.V77.7.1607.1607","volume":"77","author":"L Ugozzoli","year":"1991","unstructured":"Ugozzoli L, Yam P, Petz LD, Ferrara GB, Champlin RE, Forman SJ, et al. Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation. Blood. 1991;77:1607\u201315.","journal-title":"Blood"},{"key":"2728_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0272-2712(18)30083-0","volume":"20","author":"VM Van Deerlin","year":"2000","unstructured":"Van Deerlin VM, Leonard DG. Bone marrow engraftment analysis after allogeneic bone marrow transplantation. Clin Lab Med. 2000;20:197\u2013225.","journal-title":"Clin Lab Med"},{"key":"2728_CR19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41409-024-02348-6","volume":"59","author":"CS Tham","year":"2024","unstructured":"Tham CS, Linn YC, Koh LP. Desensitisation treatment for HLA-donor specific antibodies in ex-vivo T cell depleted haploidentical allogeneic haematopoietic stem cell transplant \u2013 a multi-centre retrospective study in Singapore. Bone Marrow Transpl. 2024;59:140.","journal-title":"Bone Marrow Transpl"},{"key":"2728_CR20","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1182\/bloodadvances.2021004862","volume":"5","author":"SO Ciurea","year":"2021","unstructured":"Ciurea SO, Al Malki MM, Kongtim P, Zou J, Aung FM, Rondon G, et al. Treatment of allosensitized patients receiving allogeneic transplantation. Blood Adv. 2021;5:4031\u201343.","journal-title":"Blood Adv"},{"key":"2728_CR21","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1126\/science.1068440","volume":"295","author":"L Ruggeri","year":"2002","unstructured":"Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097\u20132100.","journal-title":"Science"},{"key":"2728_CR22","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","volume":"23","author":"F Aversa","year":"2005","unstructured":"Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S, et al. Full Haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol. 2005;23:3447\u201354.","journal-title":"J Clin Oncol"},{"key":"2728_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1365-2141.2011.08823.x","volume":"155","author":"W Leung","year":"2011","unstructured":"Leung W. Use of NK cell activity in cure by transplant. Br J Haematol. 2011;155:14\u201329.","journal-title":"Br J Haematol"},{"key":"2728_CR24","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.1182\/blood-2022-168995","volume":"140","author":"LP Koh","year":"2022","unstructured":"Koh LP, Poon M, Quek J. Haploidentical haematopoietic cell transplantation of ex vivo TCRab-depleted grafts with CD45RA-depleted memory T cell add-back reduces chronic graft-versus-host disease and results in favourable GvHD-Relapse free survival: 5-year follow-up of 107 patients treated in a multicenter study in Singapore. Blood. 2022;140:4707\u20138.","journal-title":"Blood"},{"key":"2728_CR25","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1200\/JCO.21.01755","volume":"40","author":"M Bleakley","year":"2022","unstructured":"Bleakley M, Sehgal A, Seropian S, Biernacki MA, Krakow EF, Dahlberg A, et al. Naive T-cell depletion to prevent chronic graft-versus-host disease. J Clin Oncol. 2022;40:1174\u201385.","journal-title":"J Clin Oncol"},{"key":"2728_CR26","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1182\/blood-2004-10-4087","volume":"106","author":"Y Maeda","year":"2005","unstructured":"Maeda Y, Reddy P, Lowler KP, Liu C, Bishop DK, Ferrara JLM. Critical role of host gammadelta T cells in experimental acute graft-versus-host disease. Blood. 2005;106:749\u201355.","journal-title":"Blood"},{"key":"2728_CR27","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.bbmt.2010.03.020","volume":"16","author":"N Cantoni","year":"2010","unstructured":"Cantoni N, Hirsch HH, Khanna N, Gerull S, Buser A, Bucher C, et al. Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. Biol Blood Marrow Transpl. 2010;16:1309\u201314.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2728_CR28","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/nm.4380","volume":"23","author":"J Legoff","year":"2017","unstructured":"Legoff J, Resche-Rigon M, Bouquet J, Robin M, Naccache SN, Mercier-Delarue S, et al. The eukaryotic gut virome in hematopoietic stem cell transplantation: new clues in enteric graft-versus-host disease. Nat Med. 2017;23:1080\u20135.","journal-title":"Nat Med"},{"key":"2728_CR29","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/bmt.2014.324","volume":"50","author":"BM Triplett","year":"2015","unstructured":"Triplett BM, Shook DR, Eldridge P, Li Y, Kang G, Dallas M, et al. Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies. Bone Marrow Transpl. 2015;50:968\u201377.","journal-title":"Bone Marrow Transpl"},{"key":"2728_CR30","doi-asserted-by":"publisher","first-page":"478.e1","DOI":"10.1016\/j.jtct.2021.03.010","volume":"27","author":"L Castagna","year":"2021","unstructured":"Castagna L, Valli V, Timofeeva I, Capizzuto R, Bramanti S, Mariotti J, et al. Feasibility and efficacy of CD45RA+ depleted donor lymphocytes infusion after haploidentical transplantation with post-transplantation cyclophosphamide in patients with hematological malignancies. Transplant Cell Ther. 2021;27:478.e1\u2013478.e5.","journal-title":"Transplant Cell Ther"},{"key":"2728_CR31","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1200\/JCO.2017.72.8428","volume":"35","author":"A Bashey","year":"2017","unstructured":"Bashey A, Zhang M-J, McCurdy SR, St. Martin A, Argall T, Anasetti C, et al. Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-Cell\u2013replete haploidentical donor transplantation using post-transplant cyclophosphamide. J Clin Oncol. 2017;35:3002\u20139.","journal-title":"J Clin Oncol"},{"key":"2728_CR32","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1182\/blood.2020007535","volume":"137","author":"EJ Fuchs","year":"2021","unstructured":"Fuchs EJ, O\u2019Donnell PV, Eapen M, Logan B, Antin JH, Dawson P, et al. Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial. Blood. 2021;137:420\u20138.","journal-title":"Blood"},{"key":"2728_CR33","doi-asserted-by":"publisher","first-page":"395.e1","DOI":"10.1016\/j.jtct.2022.04.020","volume":"28","author":"RS Mehta","year":"2022","unstructured":"Mehta RS, Saliba RM, Ghanem S, Alousi AM, Rondon G, Anderlini P, et al. Haploidentical versus matched unrelated versus matched sibling donor hematopoietic cell transplantation with post-transplantation cyclophosphamide. Transplant Cell Ther. 2022;28:395.e1\u201311.","journal-title":"Transplant Cell Ther"},{"key":"2728_CR34","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/cncr.31228","volume":"124","author":"A Ruggeri","year":"2018","unstructured":"Ruggeri A, Labopin M, Bacigalupo A, G\u00fclbas Z, Koc Y, Blaise D, et al. Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide. Cancer. 2018;124:1428\u201337.","journal-title":"Cancer"},{"key":"2728_CR35","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/s41409-019-0500-x","volume":"54","author":"A Granata","year":"2019","unstructured":"Granata A, F\u00fcrst S, Bramanti S, Legrand F, Sarina B, Harbi S, et al. Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients. Bone Marrow Transpl. 2019;54:1730\u20137.","journal-title":"Bone Marrow Transpl"},{"key":"2728_CR36","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.bbmt.2019.05.017","volume":"25","author":"J Mariotti","year":"2019","unstructured":"Mariotti J, Devillier R, Bramanti S, Giordano L, Sarina B, Furst S, et al. Peripheral blood stem cells versus bone marrow for T cell\u2013replete haploidentical transplantation with post-transplant cyclophosphamide in Hodgkin Lymphoma. Biol Blood Marrow Transpl. 2019;25:1810\u20137.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2728_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1182\/blood.2021011281","volume":"138","author":"M Gooptu","year":"2021","unstructured":"Gooptu M, Romee R, St. Martin A, Arora M, Al Malki M, Antin JH, et al. HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis. Blood. 2021;138:273\u201382.","journal-title":"Blood"},{"key":"2728_CR38","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1182\/blood-2015-01-623991","volume":"125","author":"SR McCurdy","year":"2015","unstructured":"McCurdy SR, Kanakry JA, Showel MM, Tsai H-L, Bola\u00f1os-Meade J, Rosner GL, et al. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide. Blood. 2015;125:3024\u201331.","journal-title":"Blood"},{"key":"2728_CR39","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1038\/s41409-021-01328-4","volume":"56","author":"A Esquirol","year":"2021","unstructured":"Esquirol A, Pascual MJ, kwon M, P\u00e9rez A, Parody R, Ferra C, et al. Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide. Bone Marrow Transpl. 2021;56:2432\u201344.","journal-title":"Bone Marrow Transpl"},{"key":"2728_CR40","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.3324\/haematol.2016.149880","volume":"101","author":"SR Goldsmith","year":"2016","unstructured":"Goldsmith SR, Slade M, DiPersio JF, Westervelt P, Lawrence SJ, Uy GL, et al. Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. Haematologica. 2016;101:e465\u20138.","journal-title":"Haematologica"},{"key":"2728_CR41","doi-asserted-by":"publisher","first-page":"S375","DOI":"10.1016\/j.bbmt.2015.11.887","volume":"22","author":"R Ramlal","year":"2016","unstructured":"Ramlal R, Sasaki K, Cerrada SL, Srour SA, Chen J, Rondon RG, et al. Viral reactivation in haploidentical transplants using post-transplantation cyclophosphamide \u2013 a single institution experience. Biol Blood Marrow Transpl. 2016;22:S375\u20136.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2728_CR42","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1182\/blood.2020009362","volume":"137","author":"SR Goldsmith","year":"2021","unstructured":"Goldsmith SR, Abid MB, Auletta JJ, Bashey A, Beitinjaneh A, Castillo P, et al. Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis. Blood. 2021;137:3291\u2013305.","journal-title":"Blood"},{"key":"2728_CR43","doi-asserted-by":"publisher","unstructured":"Triplett BM, Muller B, Kang G, Li Y, Cross SJ, Moen J, et al. Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion. Transpl. Infect. Dis. 2018; 20, https:\/\/doi.org\/10.1111\/tid.12823.","DOI":"10.1111\/tid.12823"},{"key":"2728_CR44","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.jcyt.2024.07.007","volume":"26","author":"M Gasior Kabat","year":"2024","unstructured":"Gasior Kabat M, Li Y, Gal\u00e1n V, Mozo Y, Sisinni L, Bueno-S\u00e1nchez D, et al. Safety and efficacy of high-dose memory CD45RO+ donor lymphocyte infusion in pediatric recipients after hematopoietic stem cell transplantation. Cytotherapy. 2024;26:1458\u201364.","journal-title":"Cytotherapy"},{"key":"2728_CR45","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1182\/bloodadvances.2022007735","volume":"7","author":"JJP van Beek","year":"2023","unstructured":"van Beek JJP, Puccio S, Di Vito C, De Paoli F, Zaghi E, Calvi M, et al. Selected memory T cells infused post-haploidentical hematopoietic stem cell transplantation persist and hyperexpand. Blood Adv. 2023;7:3458\u201368.","journal-title":"Blood Adv"},{"key":"2728_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1182\/blood.2023021336","volume":"143","author":"P Merli","year":"2024","unstructured":"Merli P, Algeri M, Galaverna F, Bertaina V, Lucarelli B, Boccieri E, et al. TCR\u03b1\u03b2\/CD19 cell\u2013depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis. Blood. 2024;143:279\u201389.","journal-title":"Blood"},{"key":"2728_CR47","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.bbmt.2014.05.029","volume":"20","author":"AM Raiola","year":"2014","unstructured":"Raiola AM, Dominietto A, di Grazia C, Lamparelli T, Gualandi F, Ibatici A, et al. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts. Biology Blood Marrow Transpl. 2014;20:1573\u20139.","journal-title":"Biology Blood Marrow Transpl"},{"key":"2728_CR48","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/bmt.2012.13","volume":"47","author":"J Sanz","year":"2012","unstructured":"Sanz J, Boluda JCH, Mart\u00edn C, Gonz\u00e1lez M, Ferr\u00e1 C, Serrano D, et al. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen. Bone Marrow Transpl. 2012;47:1287\u201393.","journal-title":"Bone Marrow Transpl"},{"key":"2728_CR49","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1182\/blood-2003-01-0150","volume":"102","author":"K Rezvani","year":"2003","unstructured":"Rezvani K, Grube M, Brenchley JM, Sconocchia G, Fujiwara H, Price DA, et al. Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation. Blood. 2003;102:2892\u2013900.","journal-title":"Blood"},{"key":"2728_CR50","first-page":"637.e1","volume":"29","author":"RT Maziarz","year":"2023","unstructured":"Maziarz RT, Devine S, Garrison LP, Agodoa I, Badaracco J, Gitlin M, et al. Estimating the lifetime medical cost burden of an allogeneic hematopoietic cell transplantation patient. Transpl Cell Ther. 2023;29:637.e1\u2013637.e9.","journal-title":"Transpl Cell Ther"},{"key":"2728_CR51","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1182\/blood-2009-07-232454","volume":"114","author":"AM Leen","year":"2009","unstructured":"Leen AM, Christin A, Myers GD, Liu H, Cruz CR, Hanley PJ, et al. Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood. 2009;114:4283\u201392.","journal-title":"Blood"},{"key":"2728_CR52","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1182\/bloodadvances.2021006831","volume":"6","author":"H Kinoshita","year":"2022","unstructured":"Kinoshita H, Cooke KR, Grant M, Stanojevic M, Cruz CR, Keller M, et al. Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT. Blood Adv. 2022;6:2520\u201334.","journal-title":"Blood Adv"},{"key":"2728_CR53","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1200\/JCO.20.03106","volume":"39","author":"C Craddock","year":"2021","unstructured":"Craddock C, Friedberg JW. Immunotherapy for hematologic malignancies. J Clin Oncol. 2021;39:343\u20135.","journal-title":"J Clin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02728-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02728-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02728-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T18:02:24Z","timestamp":1768932144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02728-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2728"],"URL":"https:\/\/doi.org\/10.1038\/s41409-025-02728-6","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"20 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board of the National University Hospital (NHG DSRB 2010\/00431) and Singapore General Hospital (Singhealth CRIB 2015-2419). All methods were conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}